MSX2 is a homeodomain transcription factor that has been implicated in craniofacial morphogenesis on the basis of its expression pattern during mouse development and the finding of a missense mutation (P148H) in humans affected with Boston-type craniosynostosis. We have generated transgenic mice carrying a 34 kb DNA fragment encompassing a human MSX2 gene encoding either wild-type or mutant (P148H) MSX2. Inheritance of either transgene resulted in perinatal lethality and multiple craniofacial malformations of varying severity, including mandibular hypoplasia, cleft secondary palate, exencephaly, and median facial cleft, which are among the severe craniofacial malformations observed in humans. Transgenic mice also manifested aplasia of the interparietal bone and decreased ossification of the hyoid. Transgene-induced malformations involved cranial neural-crest derivatives, were characterized by a deficiency of tissue, and were similar to malformations associated with embryonic exposure to ethanol or retinoic acid, teratogens that cause increased cell death. Together with previous observations implicating MSX2 expression in developmentally-programmed cell death, these results suggest that wild-type levels of MSX2 activity may establish a balance between survival and apoptosis of neural crest-derived cells required for proper craniofacial morphogenesis.
INTRODUCTION
In contrast to the obvious segmentation of the axial skeleton, craniofacial development is a poorly understood process which must be executed properly for survival and which determines our physiognomy, the most uniquely human of all our physical attributes. Hox genes are expressed throughout the developing trunk and limbs, but the rostral border of expression is the third rhombomere (r3) of the embryonic hindbrain (1) . The craniofacial skeleton forms primarily from neural crest cells (NCC) that migrate from hindbrain rhombomeres into the branchial arches. NCC from r1 and r2 migrate into the first arch, whereas cells from r4 and r6 migrate into the second and third arches, respectively (2) . In response to a signal from the surrounding rhombomeres, Msx2 expression is induced within NCC of r3 and r5, which subsequently undergo apoptosis (3, 4) . Hox gene products, including Hoxa1, Hoxa2, and Hoxa3, play a role in the development of craniofacial structures derived from the second and third branchial arches, but they are not involved in the patterning of first arch derivatives (5) (6) (7) (8) . Other homeodomain proteins are expressed in cranial NCC that migrate into the first branchial arch, including Gsc, MHox, and members of the Dlx and Msx families (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Msx1 and Msx2 are particularly remarkable for their patterns of expression within many of the developing craniofacial structures in which epithelial-mesenchymal interactions occur, including the developing eyes, ears, tooth buds, nasal, maxillary, and mandibular processes, and skull bones (17, (20) (21) (22) . NCC migrating into the craniofacial processes form mesenchymal condensations that differentiate into cartilage and bone of endochondral and membranous skull, respectively (23) .
Both human mutations and knockout mice have demonstrated a role for Msx1 and Msx2 in craniofacial development. The first mutation identified caused a Pro-to-His substitution at residue 148 (P148H) of the human MSX2 protein (20) . The amino acid *To whom correspondence should be addressed In parallel with quantities of cosmid DNA equivalent to the indicated number of transgene copies in genomic DNA (lanes 1-8), 7.5 µg aliquots of BglII-digested genomic DNA from F 1 transgenic mice (lanes 9-11) were analyzed by blot hybridization using an exon 2 probe. H and M, hybridizing fragments from human and mouse genes, respectively. substitution involved the seventh residue of the homeodomain which is proline in all vertebrate Msx proteins. The P148H mutation segregated with autosomal-dominant Boston-type craniosynostosis in a large kindred (20) . Affected individuals manifested varying degrees of craniofacial malformation ranging from mild fronto-orbital recession to severe cloverleaf skull malformation; cleft soft palate was also identified in one family member (24) . Both wild-type and mutant Msx2 specifically recognized a high-affinity Msx1 binding site and repressed gene transcription, suggesting that the P148H mutation may exert its pathophysiologic effects on craniofacial development by a gain-of-function, rather than a loss-of-function or dominantnegative, mechanism (25) . Recently, a mutation resulting in an Arg-to-Pro substitution at residue 31 of the MSX1 homeodomain was shown to segregate with an autosomal dominant form of familial tooth agenesis (26) . Finally, loss of Msx1 expression resulted in mice with cleft secondary palate, agenesis of alveolar tissue of mandible and maxilla, and abnormalities of the nasal, frontal, and parietal bones which all contain neural crest-derived tissues of the first branchial arch (27) . In order to determine the effect of increased MSX2 gene dosage on craniofacial development, we have generated mice transgenic for either the wild-type or mutant human MSX2 gene, which encodes a 267 amino acid protein that is 92% identical to mouse Msx2, including 100% identity in the 60 amino acid homeodomain (20, 28) .
RESULTS

Generation of MSX2 F 0 transgenic mice
In order to obtain a large DNA fragment that included the MSX2 gene as well as essential cis-acting transcriptional regulatory sequences, clone 38C8, containing a 34 kb insert of human genomic DNA encompassing the MSX2 gene, was isolated from a chromosome 5-specific cosmid library. Restriction endonuclease analysis revealed that the two exons and one intron of the MSX2 gene extended over ∼9 kb, and that the clone also contained 11 kb and 14 kb of 5′-and 3′-flanking DNA, respectively (Fig. 1A) . A unique 3.1 kb ScaI fragment containing the MSX2 homeobox was subcloned, the nucleotide substitution responsible for the P148H missense mutation associated with Boston-type craniosynostosis was introduced by site-directed mutagenesis, and the ScaI fragment was returned to the cosmid. The 34 kb wild-type and mutant transgenes (tgMSX2wt and tgMSX2mut, respectively) were isolated by NotI digestion and microinjected into fertilized mouse eggs. These two transgenes were thus identical except that they encoded wild-type and mutant (P148H) forms of the MSX2 protein. Three tgMSX2wt and three tgMSX2mut founder (F 0 ) mice were identified by blot hybridization of DNA isolated from tail biopsies. Physical examination of these mice did not reveal any malformations. Fig. 3c for histology). 
Genotype analysis of F 1 transgenic mice
Three F 0 mice carried the mutant MSX2 (P148H) transgene. Founder mouse tgMSX2mut13 died on the second day of life due to unknown causes. Female founder tgMSX2mut15 died at 4 months of age after delivering three litters and a total of 26 offspring ( Table 1 ). The only F 1 transgenic mouse died on the first day of life due to respiratory insufficiency and postmortem examination revealed mandibular hypoplasia and cleft palate. Male founder tgMSX2mut4 had a total of 110 offspring of which 61% were non-transgenic and 39% were transgenic. All of the transgenic mice died on the first day of life due to respiratory insufficiency and all manifested craniofacial malformations ( Table 2) . Three female founders carrying the wild-type MSX2 transgene were mated to non-transgenic males. tgMSX2wt19, tgMSX2wt24, and tgMSX2wt25 each gave rise to greater than 40 F 1 mice, of which 20, 39, and 0% were transgenic, respectively ( Table 1 ). All of the transgenic F 1 mice died on the first day of life with multiple craniofacial malformations ( Table 2 ). These data indicate that there was 100% penetrance for the general phenotype of perinatal lethality and craniofacial malformations, regardless of whether the transgene encoded wild-type or mutant MSX2. The viability of F 0 mice, the lack of viability of F 1 mice, and the lower-than-expected transgene transmission frequencies suggest that founders 13, 15, 19, and 25 were mosaic for transgene integration. In the case of founders 4 and 24, the frequency of transgenic F 1 mice was higher (39%), although still less than expected, and the founders may have been either mosaic or non-mosaic but non-expressing. There was no evidence for prenatal lethality of F 1 transgenic mice, although this possibility was not definitively excluded.
Transgene copy number in genomic DNA was determined by blot hybridization using a standard curve based upon known amounts of cosmid DNA (Fig. 1B) . This analysis indicated that tgMSX2mut4, tgMSX2wt19, and tgMSX2wt24 F 1 mice carried 14, 22, and 13 copies of the transgene, respectively.
Craniofacial malformations in F 1 transgenic mice
The types of malformations identified in F 1 mice carrying the wild-type and mutant transgenes were similar as determined by an analysis of 41 tgMSX2mut4, 12 tgMSX2wt19, and 16 tgMSX2wt24 F 1 transgenic mice (Table 2 ). In addition to perinatal lethality, the other aspect of the transgenic phenotype with 100% penetrance was a variable degree of mandibular hypoplasia. This defect was often easily diagnosed by the failure of the upper and lower jaws to fully appose (compare Fig. 2a  and b) . Histologic analysis demonstrated a markedly hypoplastic lower jaw containing either two closely-spaced (Fig. 3b) or a single (Fig. 3f, g ) central incisor. Cleared skeletal preparations of transgenic mice with a single central incisor (data not shown) confirmed the midline fusion of the mandibular rami and absence of the symphysis menti that was detected histologically. Maxillary malformations of variable severity were also seen in most transgenic mice. In the mildest cases, the snout lacked the normally rounded appearance of non-transgenic littermates (Figs 2a, b, 4a and 6a). More severe malformations of the nasomaxillary region are described below. In general, however, the mandible appeared to be disproportionately reduced in size relative to the maxilla.
All F 1 mice transgenic for tgMSX2mut or tgMSXwt thus demonstrated maxillary defects, mandibular hypoplasia, and perinatal lethality. However, many tgMSX2mut4 and tgMSX2wt19 mice also presented with either cleft palate or exencephaly, but never both, suggesting that these two phenotypic manifestations were mutually exclusive. In contrast, all of the tgMSX2wt24 F 1 mice had cleft secondary palate and none had exencephaly (Table 2 ). Cleft secondary palate (Fig. 4a) was observed in two-thirds of the tgMSX2mut4 and tgMSX2wt19 F 1 mice (Table 2) . In these mice, the tongue was malpositioned within the cleft (Fig. 3b-d ) and the combination of mandibular hypoplasia, glossoptosis, and cleft palate led to both airway obstruction and insufflation of the gastrointestinal tract ( Fig. 4b) . Histologic examination of the lungs revealed that the alveoli were only minimally inflated (data not shown).
The other mutually-exclusive phenotype was exencephaly, which was observed in one-quarter of the tgMSX2mut4 and tgMSX2wt19 F 1 transgenic mice, with failure of cranial neural tube closure and a defect of the overlying skull (Fig. 2e, f) . These animals also died of respiratory insufficiency, possibly on a neurogenic basis. Exencephaly was confirmed by histological demonstration that the ependymal layer covering the brain was in direct continuity with skin covering the cranial base (Fig. 5) . The degree of cerebral development in the exencephalic mice varied in severity, ranging from more mild malformations to apparent anencephaly. These cranial defects were identified in mice delivered by caesarean section at E19 and thus were not traumatic in their primary etiology, although mice delivered spontaneously did show evidence of hemorrhage and tissue disruption due to the absence of boney protection for the brain. In several mice with cleft palate, less severe skull malformations were identified rather than exencephaly (Fig. 2g) .
Whereas tgMSX2wt24 mice had a fairly uniform phenotype consisting of cleft palate and mandibular hypoplasia (without midline fusion), several other craniofacial malformations were variably present in tgMSX2mut4 and tgMSX2wt19 mice ( Table 2) . A subset of mice with cleft secondary palate or exencephaly also manifested a midline facial cleft that included incomplete midline fusion of the maxillary and nasal processes that was variable in its severity, ranging from cleft lip due to incomplete midline fusion of the premaxillary soft tissues (Fig. 2b, d ) to complete failure of nasal process fusion (Fig. 2c) with neural tissue virtually apposed to the tongue (Fig. 3g, h ). The more severe facial clefts were seen in tgMSX2mut4 mice and the more mild clefts were seen in tgMSX2wt19 mice. Hypoplasia or aplasia of the eyelids was observed in 25% of tgMSX2mut4 F 1 mice (Figs 2e, g, h and 3c, d) and 12.5% of tgMSX19wt19 F 1 mice (Table 2) . More severe ocular defects were observed in several mice, including in coloboma of the retina and optic nerve (Fig. 3d) . Transgenic mice also manifested a variable reduction in the size of the external ear which was not analyzed quantitatively.
The results described above indicate that most of the malformations were seen in mice carrying either tgMSX2wt or tgMSX2mut. However, analysis of cleared skeletal specimens revealed two defects which were present in tgMSX2mut4 mice and absent in the non-transgenic and tgMSX2wt24 mice that were studied. First, examination of the skull bones revealed that compared to non-transgenic mice (n = 21), tgMSX2wt24 mice (n = 3) demonstrated a complete midline cleft of the interparietal bone (data not shown), whereas in tgMSX2mut4 mice without exencephaly (n = 10) the interparietal bone was completely absent (Fig. 6a) . Second, ossification of the hyoid bone was markedly decreased in tgMSX2mut4, relative to non-transgenic and tgMSX2wt24 mice (Fig. 6b) . Whereas many of the observed malformations involved structures derived from the first and second branchial arches, the hyoid defect indicates involvement of the third arch as well. Cleared skeletal preparations from tgMSX2wt19 mice were not examined. Since the phenotypes of tgMSX2mut4 and tgMSX2wt19 mice were more similar than the phenotypes of tgMSX2wt19 and tgMSX2wt24 mice (Table 2) , it is unclear whether the observed differences between tgMSX2mut4 and tgMSX2wt24 mice were due to inheritance of mutant vs wild-type transgenes or another cause, such as different levels of transgene expression, that might account for the overall differences in phenotype between tgMSX2mut4 and tgMSX2wt24 mice.
DISCUSSION
In this paper we demonstrate the presence of multiple severe craniofacial malformations, involving structures that arise from the first, second, and third branchial arches, in mice that inherited human MSX2 transgenes. There are several possible pathogenetic mechanisms that might underlie the observed phenotypes. First, transgene integration may have disrupted a mouse gene that is essential for craniofacial development. However, the observation that the transgenic phenotype was dominantly inherited in multiple, independently-derived lines rules out insertional mutagenesis as a possible etiology. Second, we introduced a large human genomic DNA fragment into the mouse germline in order to increase the probability of including all cis-acting transcriptional control elements required for proper developmental regulation of MSX2. We cannot exclude the presence of a second gene within the 34 kb fragment, although this possibility is unlikely as the gene would need to be small and in close proximity to MSX2 in order to be included intact within the transgene. It should be noted that MSX1 and MSX2 map to human chromosomes 4p16.1 and 5q34-35, respectively (20, 29) , and are therefore not contiguous. A third and favored explanation for the observed phenotypes is that expression of human MSX2 in cells already expressing mouse Msx2 adversely affects craniofacial development. Additional experiments will be required to demonstrate transgene expression within Msx2-expressing NCC of the rhombencephalon and/or branchial arches. These studies require a transgenic male for mating to females that are sacrificed at various gestational intervals in order to correlate transgene expression with abnormal embryonic development. The only male founder, tgMSX2mut4, became infertile at the time those experiments were initiated. It will therefore be necessary to generate new transgenic founders in order to extend these studies. A transgene consisting of the intact mouse Msx2 gene (with LacZ inserted into exon 1) as well as 5.2 kb and 3 kb of 5′-and 3′-flanking DNA was expressed in a pattern that closely resembled the endogenous Msx2 gene, including expression in craniofacial mesenchyme at E12.5 (30) . It is therefore likely that our 34 kb transgene, consisting of the intact human MSX2 gene with 11 kb and 14 kb of 5′-and 3′-flanking DNA, includes positive and negative transcriptional regulatory elements that are functionally analogous to those present within the less extensive mouse transgene.
MSX2 (P148H) and craniofacial malformations in humans
Our studies were performed in part to investigate the molecular basis by which inheritance of the MSX2 (P148H) allele results in craniosynostosis. We hypothesized that this missense mutation might result in increased biological activity of the MSX2 protein.
If such were the case, then overexpression of the wild-type protein (as a consequence of increased gene dosage in transgenic mice) might also have phenotypic effects. The presence of craniofacial malformations in both tgMSX2mut and tgMSX2wt F 1 mice was consistent with these hypotheses. However, the observed mouse malformations were more severe than those observed in humans with Boston-type craniosynostosis (20, 24) . Two likely explanations which are not mutually exclusive involve MSX2 gene dosage and genetic background. We have demonstrated that all transgenic lines contained multiple copies of the human MSX2 gene in addition to the endogenous mouse Msx2 genes. Although we have no data relating copy number to the level of transgene expression, it is likely that expression of Msx2/MSX2 protein is increased in the transgenic mice and that the effect of this overexpression on craniofacial development is considerably greater than the effect of simple heterozygosity for the MSX2 (P148H) allele. A second probable contributory factor is genetic background. Two mutually-exclusive phenotypic presentations, cleft secondary palate and exencephaly, were identified in the offspring of founders that arose from the mating of (C57BL/6 × SJL)F 1 mice. Genetic differences between the C57BL/6 and SJL strains segregating in the F 1 mice may have influenced the phenotypic presentation. Analysis of offspring derived from matings of transgenic mice to isogenic C57BL/6 and SJL mice would be informative in this regard, but we are prevented from doing so by the lack of fertile transgenic mice.
In MSX2 transgenic mice in which a complete skull developed, there was no evidence of craniosynostosis (data not shown). Our results stand in contrast to the human syndrome and also differ from the analysis of transgenic mice in which either wild-type or mutant mouse Msx2 was expressed from a heterologous (cytomegalovirus immediate-early or TIMP1 gene) promoter, as those mice were reported to exhibit premature sutural closure and ectopic bone formation (31) . Those results are difficult to interpret because the sutural histology appeared abnormal rather than advanced and expression of the transgenes differed temporospatially from that of the endogenous Msx2 gene. Our negative results may reflect the inability to study transgenic mice beyond the first day of life and/or the effects of genetic background. In the B6CBAF 1 mice which were used for the CMV-Msx2 and TIMP1-Msx2 transgenic studies described above, suture closure was not detected until postnatal days 13 to 17 (31) .
The most striking finding of our study is that MSX2 transgenic mice manifest common severe craniofacial dysplasia sequences observed in humans: Robin cleft palate sequence, anencephaly/ exencephaly, and frontonasal dysplasia (median facial cleft) sequence (42) . These developmental defects demonstrate multifactorial inheritance patterns in human populations which suggest that a complex interplay of genetic and environmental factors (as described below) determine their incidence and severity. Further analysis of the malformations in these mice may therefore provide insights into the pathogenesis of the analagous human birth defects.
Similar phenotypes associated with Msx1 or Msx1/Msx2 deficiency and Msx2 overexpression
Msx1 and Msx2 are 97% identical (58/60 residues) in the homeodomain, suggesting that they bind to similar DNA sequences. This prediction was confirmed in the context of in vitro electrophoretic mobility shift assays (25) . Msx1 and Msx2 sequences diverge outside of the residues immediately flanking the homeodomain, suggesting that these proteins may have distinct biological functions. However, in transcription assays, Msx1 and Msx2 both function as repressors (25, 32) . In addition, Msx1 and Msx2 expression patterns during craniofacial development, although not identical, overlap considerably. These observations have led several investigators to hypothesize that Msx1 and Msx2 are functionally redundant (27, 32) . It was therefore surprising that the phenotype of mandibular hypoplasia, cleft secondary palate, respiratory insufficiency, gaseous abdominal distension, and perinatal lethality was shared by MSX2 transgenic mice and Msx1 -/-knockout mice (27) . Likewise, even though Msx1 and Msx2 are both expressed in the developing mouse limbs (33) , neither MSX2 transgenic mice nor Msx1 -/-knockout mice manifest any limb abnormalities. The similar phenotypic effects of Msx1 deficiency and Msx2 overexpression raise the possibility that, in at least some tissues, these two factors may have antagonistic effects. Mice deficient for both Msx1 and Msx2 manifest exencephaly and cleft secondary palate, whereas these phenotypes are not observed in mice deficient for Msx2 alone (R. Maas, personal communication). The similar effects of Msx2 overexpression and Msx1 or Msx1/Msx2 deficiency suggest a complex functional interaction between these two factors during craniofacial development.
Phenotypic similarities between MSX2 transgenic mice and other mutant mice
In addition to MSX2 transgenic and Msx1 knockout mice, various combinations of eyelid dysplasia, mandibular hypoplasia, cleft secondary palate, respiratory insufficiency, abdominal distension, and perinatal lethality have been described in mice deficient for expression of the homeodomain proteins Dlx2, Gsc, Hoxa2, Hoxa3, and Mhox (6, 8, (34) (35) (36) and the signal transduction molecules activin-βA, activin receptor II, and follistatin, and activin-βB (37) (38) (39) (40) . Each of these mutations also affects mandibular development. Mandibular hypoplasia results in posterior displacement of the tongue (glossoptosis) which may interfere with palatal closure, resulting in the cleft and airway obstruction by the malpositioned tongue, a pathogenetic mechanism referred to as the Robin sequence which has an incidence of 1 in 30 000 live births (41) (42) (43) .
Malformation or aplasia of several different bones of the skull was identified in Dlx2, Gsc, Hoxa2, MHox, and Msx1 deficient mice (6, 27, (34) (35) (36) and in transgenic mice ectopically expressing Hoxd4 from the Hoxa1 promoter (44) . However, aplasia of the interparietal bone appears to be unique to mice transgenic for MSX2 (P148H). In Hoxa3 deficient mice the lesser horn of the hyoid was absent (8), a milder phenotype than the marked deficiency of bone observed in tgMSX2mut mice. Both exencephaly and midline facial clefts were also observed in mice deficient for the transcription factor AP-2 (45, 46) . AP-2 is normally expressed in cranial NCC and expression is inducible by retinoic acid (46) . Midline nasomaxillofacial clefts, and exencephaly were also seen in mice deficient for both retinoic acid receptor (RAR) α and γ (47). Other malformations shared by these mice and MSX2 transgenic mice include cleft palate, coloboma of the retina and optic nerve, and eyelid abnormalities. The similar phenotypes of these mice suggest that AP-2, MSX1, MSX2, RARα, and RARγ may be required together for the proper execution by NCC of one or more specific genetic programs required for normal craniofacial development.
Msx2, teratogens, and apoptosis
In addition to sharing phenotypic similarities with several knockout mice, the phenotype associated with inheritance of an MSX2 transgene is also remarkably similar to the effect of teratogens. Exposure of mouse embryos to ethanol on E8 or E9 resulted in the development of cleft palate, exencephaly, mandibular hypoplasia, and midline facial clefts (48) (49) (50) . Analysis of these mice revealed that at sites of developmentally programmed cell death there was an increased area and density of dying cells. Within the rhombencephalon, r3 and r5 were sites of markedly increased cell death (51) . Exposure of mouse embryos to retinoic acid at E8 or E9 also resulted in increased death of rhombencephalic NCC, leading to cleft secondary palate, mandibular and maxillary deficiencies (50) . Expression of Msx2 in the rhombencephalon was also temporally and spatially correlated with the selective apoptosis of NCC in r3 and r5 (3, 4) . Taken together, these results suggest that in MSX2 transgenic mice, the combined levels of Msx2/MSX2 may induce the death of an increased number of NCC, resulting in a deficiency of cells that populate the branchial arches and participate in craniofacial morphogenesis. Msx2 may thus regulate a balance between survival and apoptosis of rhombencephalic neural crest-derived cells that is required for proper craniofacial development. One intriguing hypothesis which follows from these conclusions is that the increased death of neural crest-derived cells associated with the development of craniofacial malformations, either in embryos with genetic defects such as AP-2 deficiency (45) or in embryos exposed to teratogens such as ethanol or retinoic acid (50) , may involve an induction of Msx2 expression within apoptotic cells.
MATERIALS AND METHODS
Construction of transgenes
The Los Alamos human chromosome 5-specific cosmid library was screened by hybridization with a mixture of two probes representing PCR-amplified MSX2 exons 1 and 2. The 34 kb NotI insert fragment from clone 38C8 (in the vector SuperCos-1) was transferred to the NotI site of the cosmid vector pWE15sm, in which the ScaI site of pWE15 (Stratagene) was converted to an MluI site. A 3.1 kb ScaI fragment was isolated from pWE15sm/38C8 (Fig. 1) and subcloned into pUC19MScaIR, in which the ScaI site in the amp R gene was converted to an EcoRV site and the KpnI site in the polylinker was converted to a ScaI site. Site-directed mutagenesis was performed with pUC19MScaIR/ Sca3.1 using the mutagenesis primer 5′-CCGCGCACGCACTTT-ACCACATCCC-3′ (mutation underlined) which converts MSX2 codon 148 from CCC (Pro codon) to CAC (His codon). The presence of this mutation and absence of any other coding sequence mutations were confirmed by nucleotide sequence analysis. The mutated ScaI fragment was then returned to pWE15sm/38C8. All mutagenesis procedures were performed using the Transformer Site-Directed Mutagenesis Kit (Clontech).
Generation and genotype analysis of transgenic mice
The 34 kb transgene fragments were isolated and purified from pWE15sm/38C8wt and pWE15sm/38C8mut by NotI digestion, agarose gel electrophoresis, electroelution, cesium chloride density gradient centrifugation, and dialysis against microinjection buffer (10 mM Tris HCl, pH 7.5/0.25 mM EDTA). DNA was microinjected at a concentration of 5 ng/µl into fertilized eggs derived from matings of (C57BL/6 × SJL)F 1 mice (Jackson Laboratory) using standard procedures (52) . Two-cell embryos were transferred to the oviducts of surrogate CD-1 female mice (Charles River). Genomic DNA extracted from mouse tail biopsies was digested with BglII and analyzed by blot hybridization using a 32 P-labelled MSX2 exon 2 probe. Hybridization signals were quantitated by scanning laser densitometry. For the standard curve using cloned DNA, r 2 = 0.931.
Pathological analysis
For histological analysis, newborn mice were sacrificed by methoxyflurane inhalation overdose, fixed in 10% neutral-buffered formalin or Bouin's solution, and paraffin-embedded sections were sectioned in a frontal plane and stained with hematoxylin and eosin. For skeletal analysis, neonates were sacrificed, skinned, eviscerated, fixed in ethanol for several weeks, and the skeletons were stained with alizarin red S (to reveal ossified bone) and alcian blue 8GX (to reveal cartilage) (both from Sigma), destained by rinsing with water, and cleared by passage through increasing concentrations of glycerol (53) .
